Dr Donald E Christensen, DO | |
57950 Leavenworth St, Attn Credentials Office, Mcconnell Afb, KS 67221-3506 | |
(316) 759-5864 | |
(316) 759-5038 |
Full Name | Dr Donald E Christensen |
---|---|
Gender | Male |
Speciality | Preventive Medicine - Preventive Medicine/occupational Environmental Medicine |
Location | 57950 Leavenworth St, Mcconnell Afb, Kansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1912993684 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Dr Donald E Christensen, DO 57950 Leavenworth St, Attn Credentials Office, Mcconnell Afb, KS 67221-3506 Ph: (316) 759-5864 | Dr Donald E Christensen, DO 57950 Leavenworth St, Attn Credentials Office, Mcconnell Afb, KS 67221-3506 Ph: (316) 759-5864 |
News Archive
Tibotec Pharmaceuticals today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for TMC278 (rilpivirine), an investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), being studied for once-daily use with other antiretroviral agents in treatment-naive HIV-1-infected adults. If approved, TMC278 will be the third anti-HIV compound to be introduced by Tibotec Pharmaceuticals.
Individuals with many different psychiatric disorders have a higher tendency to choose smaller, immediate rewards over larger, delayed rewards, a study led by Hamilton researchers has found.
During embryonic development, the all-important coronary arteries arise from cells previously considered incapable of producing them, according to scientists at Albert Einstein College of Medicine of Yeshiva University.
Mylan Inc. today announced that it has entered into settlement and license agreements with Forest Laboratories and Merz Pharmaceuticals related to Namenda® Tablets, 5 mg and 10 mg, known generically as Memantine Hydrochloride (HCl) Tablets.
› Verified 6 days ago